Domain Therapeutics Funding: $53M Raised, Series A (2022)
Domain Therapeutics is based in Strasbourg, France. It has raised $53M in total funding. Latest round: Series A.
Domain Therapeutics funding overview
Domain Therapeutics is based in Strasbourg, France. Domain Therapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2022. The round record for Domain Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Panacea Venture, CTI Life Sciences, 3B Future Health Fund, adMare BioInnovations, Schroders Capital, Omnes and 4 others. 10 distinct backers are named across the disclosed rounds.
Domain Therapeutics at a glance
Total raised
$53M
Latest round
Series A
Latest round date
May 2022
Headquarters
Strasbourg, France
Notable investors
Panacea Venture, CTI Life Sciences, 3B Future Health Fund, adMare BioInnovations, Schroders Capital, Omnes, Turenne Capital, Theodorus
Frequently asked about Domain Therapeutics funding
How much has Domain Therapeutics raised?
Domain Therapeutics has raised $53M in total disclosed funding across the rounds on record.
Who has invested in Domain Therapeutics?
Panacea Venture, CTI Life Sciences, 3B Future Health Fund, adMare BioInnovations, Schroders Capital, Omnes are named among the investors backing Domain Therapeutics.
What was the latest Domain Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2022.
Where is Domain Therapeutics based?
Domain Therapeutics is based in Strasbourg, France.
When did Domain Therapeutics last raise?
The last disclosed Domain Therapeutics round closed in May 2022 at Series A.
Round data for Domain Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Strasbourg and backer lists below.
